Danone (DN) Barclays 19th Annual Global Consumer Conference summary

Strategic direction and market outlook

• Renew Danone's second chapter focuses on category pivoting, broadening reach, and disciplined expansion, leveraging science and consumer focus to drive growth.

• Protein and gut health are key growth drivers, with products like Oikos Pro and Activia showing strong momentum, and plant-based offerings evolving to plant-powered, especially in Europe.

• Distribution has diversified beyond mass retail, enhancing resilience and supporting innovation-driven growth.

• The company emphasizes resilience through geographic and portfolio diversity, aiming for consistent 3–5% growth bands.

• Constructive dissatisfaction drives ongoing improvement, with recognition of both high-performing and underperforming areas.

Regional performance and category trends

• EDP (Essential Dairy and Plant-based) is growing globally, led by Europe, Asia, and Latin America, while North America is improving as capacity comes online.

• U.S. EDP faces capacity constraints but expects progressive improvement, with new product formats and a focus on protein and fiber trends.

• European EDP is accelerating, with Activia and kefir driving growth and a renewed focus on gut health and naturalness.

• Plant-based brand Alpro is thriving in Europe, while Silk in the U.S. is being repositioned with a focus on protein and yogurt, aiming for progress within a year.

• Specialized Nutrition in China is expected to return to mid-single-digit growth, driven by premiumization, urban penetration, and market consolidation.

Emerging markets and growth engines

• Early Life Nutrition is balanced across China, Europe, and emerging markets, with high single- to double-digit growth in regions like Vietnam, Latin America, and India.

• India is a strategic priority, with a systematic, profitable approach to building scale in infant nutrition.

• The company is intentionally allocating resources to emerging markets, focusing on brand building and leveraging the Aptamil platform.